The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Medication reviews in the community: results of a randomized, controlled effectiveness trial
Open accessAbstract
Aims To examine the effectiveness of a multidisciplinary service model delivering medication review to patients at risk of medication misadventure in the community. Methods The study was carried out in three Australian states; Queensland, New South Wales and Western Australia, and conducted as a randomized, controlled effectiveness trial with the general practitioner (GP) as the unit of randomization. In total, 92 GPs, 53 pharmacists and 400 patients enrolled in the study. The multidisciplinary service model consisted of GP education, patient home visits, pharmacist medication reviews, primary healthcare team conferences, GP implementation of action plans in consultation with patients, and follow‐up surgery visits for monitoring. Effectiveness was assessed using the four clinical value compass domains of (i) functional status, (ii) clinical outcomes, (iii) satisfaction and (iv) costs. The domains of functional status (assessed by the health‐related quality of life measure SF‐36 subscales) and clinical outcomes (as assessed by adverse drug events (ADEs), number of GP visits, hospital services and severity of illness) were measured at baseline and endpoint. Satisfaction was measured by success in implementation and by participant satisfaction at endpoint, and costs (as assessed using medication and healthcare service costs, less intervention costs) were measured preintervention and during the trial. In addition, process evaluation was conducted for intervention patients, in which problems and recommendations from the medication reviews were described. Results The model was successfully implemented with 92% of intervention GPs suggesting that the model had improved the care of participating patients, a view shared by 94% of pharmacists. In addition, positive trends in clinical outcomes (ADEs and severity of illness) and costs (an ongoing trend towards reduction in healthcare service costs) were evident, although the trial was limited to a 6‐month intervention time. No differences between intervention and control groups were identified for the health‐related quality of life domain. The cost–effectiveness ratio for the intervention based on cost savings, reduced adverse events and improved health outcomes was small. The most common problems identified in the medication reviews were potential adverse drug reactions, suboptimal monitoring and adherence/lack of concordance issues. In total, 54.4% of recommendations were enacted, and 23.9% were implemented precisely as recommended in the medication review. Follow‐up evaluation showed that 70.9% of actions had a positive outcome, 15.7% no effect and 3.7% had a negative outcome. Conclusions Most studies emphasize efficacy and the best achievable clinical outcomes rather than whether an intervention will be effective in practice. The current trial showed that three of the four domains in the clinical value compass showed trends of improvement or were indeed improved in the relatively short follow‐up period of the trial, suggesting that a service based on this model could achieve similar benefits in practice. A domiciliary medication review programme similar to this model has now been implemented into national Australian practice, where GPs and pharmacists are reimbursed by the Australian government for the provision of these services.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria for evaluating evidence on public health interventions
Rychetnik, L., Frommer, M., Hawe, P., & Shiell, A. (2002) · Journal of Epidemiology and Community Health · doi:10.1136/jech.56.2.119 · Cited by 1,042
Cited by
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Interventions to improve the appropriate use of polypharmacy for older people
Rankin, A., Cadogan, C. A., Patterson, S. M., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub4 · Cited by 511
Holland, R., Desborough, J., Goodyer, L., Hall, S., Wright, D., & Loke, Y. K. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03071.x · Cited by 365
Clinical pharmacology in the geriatric patient
Hilmer, S. N., McLachlan, A. J., & Le Couteur, D. G. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00473.x · Cited by 296
Interventions that can Reduce Inappropriate Prescribing in the Elderly: A Systematic Review
Kaur, S., Mitchell, G., Vitetta, L., & Roberts, M. S. (2009) · Drugs & Aging · doi:10.2165/11318890-000000000-00000 · Cited by 290
Self-citation
Metadata
- Authors
- Sorensen, L., Stokes, J. A., Purdie, D. M., Woodward, M., Elliott, R., & Roberts, M. S.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2004-10-28
- Volume
- 58
- Issue
- 6
- Pages
- 648-664
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2002084004
- Cited by
- 215
- References
- 1
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medication reviews in the community: results of a randomized, controlled effectiveness trial. https://app.cochat.ai/papers/10.1111/j.1365-2125.2004.02220.x
- The paper
- Sorensen, L., Stokes, J. A., Purdie, D. M., Woodward, M., Elliott, R., & Roberts, M. S. (2004). Medication reviews in the community: results of a randomized, controlled effectiveness trial. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2004.02220.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.